Show notes
In his weekly clinical update, Dr. Griffin discusses the CDC vaccine advisory group recommending the newly approved RSV vaccines, association of culturable-virus detection and household transmission of SARS-CoV-2, prevention of COVID-19 following a single intramuscular administration of Adintrevimab, real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19, and COVID-19 convalescent plasma outpatient therapy to prevent outpatient hospitalization.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- CDC vaccine advisory group recommends RSV vaccines
- Association of culturable-virus detection and household transmission of SARS-CoV-2 (JID)
- Prevention of COVID-19 following intramuscular administration of Adintrevimab (OFID)
- Real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19 (CID)
- COVID-19 convalescent plasma outpatient therapy to prevent hospitalization (CID)
- Contribute to our FIMRC fundraiser at PWB
- Letters read on TWiV 1018
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv